Systematic Reviews of Treatments for Pneumonia

Follow the links below to find summaries of systematic reviews of the evidence for the effectiveness of treatments for pneumonia.
Reviewed February 2011

Printer friendly page Printer friendly page

17 Resources Found

Results 1 to 17 displayed.

Title:   Azithromycin for acute lower respiratory tract infections
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Acute lower respiratory tract infections (LRTI) are one of the most common diagnoses in outpatient settings. They range from acute bronchitis and acute exacerbations of chronic bronchitis to pneumonia. Azithromycin is a subclass of macrolide antibioti...
Date:   Aug 2011
Title:   Vitamin C for preventing and treating pneumonia
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Pneumonia is an infection of the lungs caused by bacteria, viruses or other infectious agents. Its clinical diagnosis is sometimes difficult. Pneumonia is more common in young children and in the aged. In low-income countries it causes two million death...
Date:   Apr 2011
Title:   Corticosteroids for pneumonia
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Pneumonia is an acute respiratory disease that is usually caused by bacteria but it can also be caused by other infectious agents such as fungi, parasites and viruses. Corticosteroids can act as an anti-inflammatory agent for patients with pneumonia but...
Date:   Dec 2010
Title:   Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Pneumocystis jiroveci is a fungus causing pneumonia mainly among patients with an impaired immune system, such as those infected with the human immunodeficiency virus (HIV), cancer patients, following organ transplantation, patients receiving immune sup...
Date:   Dec 2010
Title:   Short-course versus long-course antibiotic therapy for non-severe community-acquired pneumonia in children aged 2 months to 59 months
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Pneumonia is a major cause of mortality in children under five years of age. Treatment of pneumonia requires the use of an effective antibiotic in adequate doses for an appropriate duration. In most cases, treatment ranges between 7 and 14 days, but thi...
Date:   Sep 2010
Title:   Vitamin A for non-measles pneumonia in children
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Acute respiratory infections, mostly in the form of pneumonia, are the leading cause of death in children under five years of age living in low-income countries. Vitamin A supplementation has been found to reduce mortality and the severity of respirator...
Date:   Aug 2010
Title:   Zinc supplementation for the prevention of pneumonia in children aged 2 months to 59 months
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Zinc is an essential element for growth and development of children. Its deficiency is associated with increased risk of infection, particularly diarrhoea and pneumonia. Zinc supplementation in children has been reported to prevent pneumonia; however, i...
Date:   Jan 2010
Title:   Antibiotics for community-acquired pneumonia in children
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Pneumonia is the leading cause of mortality in children under five years of age. Most cases of community-acquired pneumonia (CAP) in low-income countries are caused by bacteria. This systematic review identified 27 randomised controlled trials, enroling...
Date:   Sep 2009
Title:   Over-the-counter (OTC) medications to reduce cough as an adjunct to antibiotics for acute pneumonia in children and adults
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Over-the-counter (OTC) medications, including mucolytics and antitussives, are commonly used by patients and recommended by healthcare staff as adjuncts in the treatment of pneumonia. In this review we found insufficient evidence to draw any conclusions...
Date:   Jul 2009
Title:   Antibiotics for community acquired pneumonia in adult outpatients
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Pneumonia, or infection involving the lungs, is the sixth most common cause of death worldwide. Pneumonia is especially life-threatening in older people and people with other illnesses that may affect the immune system (such as diabetes). Antibiotics ar...
Date:   Jul 2009
Title:   Antibiotic prophylaxis to reduce respiratory tract infections and mortality in adults receiving intensive care
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Infections acquired in intensive care units (ICUs) are important complications of the treatment of patients with very severe diseases who need ventilation (mechanical breathing support). Some people will die because of these infections. Considerable eff...
Date:   Mar 2009
Title:   Quantitative versus qualitative cultures of respiratory secretions for clinical outcomes in patients with ventilator-associated pneumonia
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Ventilator-associated pneumonia (VAP) is a condition which occurs in patients mechanically-ventilated for more than 48 hours and can significantly increase the mortality of ICU patients. The best method of diagnosing VAP and identifying the causative or...
Date:   Feb 2008
Title:   Intra-pleural fibrinolytic therapy versus conservative management in the treatment of adult parapneumonic effusions and empyema
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Infected purulent pleural effusions (empyema) with isolated collections (loculations) of fluid or pus (complicated parapneumonic effusions) may develop with pneumonia. Drainage of this infected fluid via an intercostal catheter is important in healing. ...
Date:   Jan 2008
Title:   Empiric antibiotic coverage of atypical pathogens for community-acquired pneumonia in hospitalized adults
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Agents which cause pneumonia are traditionally divided into 'typical' and 'atypical', each dictating a distinct antibiotic treatment. Atypical agents refer to certain bacteria - namely, Legionella pneumophila (L. pneumophila), Mycoplasma pneumoniae (M. ...
Date:   Nov 2007
Title:   Vaccines for preventing pneumococcal infection in adults
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Streptococcus pneumoniae is responsible for illness and death in adults worldwide, usually from pneumonia and less often from invasive pneumococcal disease (IPD). Vaccination (using pneumococcal polysaccharide vaccine (PPV)) in different populations mig...
Date:   Sep 2007
Title:   Closed tracheal suction systems versus open tracheal suction systems for mechanically ventilated adult patients
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   The comparison of open and closed suction systems shows them to have similar results in terms of safety and effectiveness. Tracheal secretions in mechanically ventilated patients are removed using a catheter via the endotracheal tube. The suction cathet...
Date:   Aug 2007
Title:   Granulocyte-Colony Stimulating Factor (G-CSF) as an adjunct to antibiotics in the treatment of pneumonia in adults
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Pneumonia, or infection involving the lungs, is responsible for a significant number of deaths worldwide. Pneumonia is especially life-threatening in older people and people with other illnesses that may affect the immune system (such as diabetes). In a...
Date:   Jan 2007

Results 1 to 17 displayed.